Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbonic anhydrase II (CA II) is a zinc metalloenzyme that catalyzes the reversible hydration of carbon dioxide. It is crucial for pH regulation, respiration, ion transport, and acid-base balance in tissues. CA II plays key roles in renal bicarbonate reabsorption, bone resorption, and central nervous system pH homeostasis. Deficiency or mutations can cause osteopetrosis with renal tubular acidosis. It is a therapeutic target for conditions like glaucoma, where inhibition reduces intraocular pressure.
Inhibition of carbonic anhydrase activity, reducing bicarbonate production and affecting fluid secretion/pH control.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbonic Anhydrase II Isoenzyme (CA II).